Exchange: NASDAQ·Updated 11:13 AM EDT
PASG logo

PASG Passage Bio Inc

$4.65
$0.0351
(0.76%)
Today
Reported EarningsMar 3
Mkt Cap$14.83M
Vol3,194.00

About PASG

Passage Bio, Inc. operates as a genetic medicines company. It focuses on development of therapies for central nervous system disorders. The company was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.
56

Bullish Sentiment

How do you feel about PASG?

Advertisement|Remove ads.